fb-pixel tracker
News

Caris Life Sciences Highlights Gene Expression Profiling Findings at 12th Annual International Congress of Human Genetics

Data Presented Shows Clinical Utility of Molecular Profiling Helping Physicians Select More Effective Therapeutic Treatments for Cancer Patients   IRVING, TX, October 14-15, 2011 — Caris Life Sciences™, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality molecular profiling, and blood-based diagnostic services, presented this week at the … Continued

Caris Life Sciences Presents Key Biomarker Findings at 2011 ASCO Breast Cancer Symposium

Data Highlights Potential Clinical Utility of Molecular Profiling in Uncovering Therapeutic Options to Treat Breast Cancer IRVING, TX, September 13, 2011 — Caris Life Sciences™, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic services, this week at the ASCO Breast … Continued

Caris Life Sciences Announces Key Findings in Cancer Biomarker Expression

HER2 Gene Overexpression Found in Array of Cancers Beyond Breast Cancer IRVING, TX, June 06, 2011 — Caris Life Sciences™, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic services, announced today that its recent research highlights the clinical utility of … Continued

Caris Life Sciences Presents Circulating Microvesicle Research Findings at American Urological Association Annual Meeting

Data Shows Diagnostic Promise for Blood-Based Prostate Cancer Detection Test IRVING, TX, May 18, 2011 — Caris Life Sciences, Inc., a leading bioscience company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling and blood-based diagnostic services, this weekend presented a poster highlighting the potential of a circulating microvesicle … Continued

Key Findings in Cancer Biomarker Expression Highlighted at 2011 Annual Meeting of the American Association for Cancer Research

Two Presented Posters Validate Clinical Utility of Molecular Profiling in Guiding Targeted Cancer Treatment IRVING, TX, April 8, 2011 — Caris Life Sciences, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic services, this week presented clinical data that validated the … Continued

Potential Benefits of Analyzing Circulating Microvesicles for Cancer Detection and Monitoring Showcased at the 2011 Annual Meeting of the American Association for Cancer Research

Five Presented Posters Demonstrate Promise of New Technology Being Developed for Cancer Testing IRVING, TX, April 7, 2011 — Caris Life Sciences, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling and blood-based diagnostic services, this weekend presented significant findings regarding the potential role … Continued

Caris Life Sciences To Present on Biomarker Expression at the Society of Gynecologic Oncologists 2011 Annual Meeting on Women’s Cancer

Symposium Will Focus on the Impact of Molecular Profiling in Guiding Ovarian Cancer Therapy Selection IRVING, TX, March 4, 2011 —  Caris Life Sciences, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling, and blood-based diagnostic services, today announced highlights from the company’s upcoming … Continued

Caris Life Sciences Presents Key Findings on Transformative Circulating Microvesicle Technology (cMV) at The International Workshop on Exosomes 2011

Two Ph.D.s from Caris Life Sciences Share New Data in support of a Proprietary Blood-Based Technology demonstrating Promise for Diagnosis, Prognosis and Theranosis of Prostate Cancer and other Complex Diseases IRVING, TX, January 21, 2011 — Caris Life Sciences, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest-quality anatomic … Continued

Caris Life Sciences Reports 2010 Highlights

Leading Biosciences Company’s 2010 Performance Characterized by Cutting-Edge Technology Advancements and Significant Growth IRVING, TX, January 18, 2011 — Caris Life Sciences, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest-quality anatomic pathology, molecular profiling, and blood-based diagnostic services, today announced key highlights of its 2010 performance. The importance … Continued

1 18 19 20 21

About Our News

Search to find the latest new about Caris Molecular Intelligence®, sign up for news alerts, and be sure to follow us on social media.